10,000+ stock pitches from top investors available on joinyellowbrick.com
BAKER BROS. ADVISORS LP 13F Holdings
Holdings from the most recent 13F from BAKER BROS. ADVISORS LP
Filed: 2023-08-14 (Q2 2023) | Holdings: 107 | Value: $17.3B | Filing Link
PREMIUM
Author Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Filing Returns
Returns are calculated from when the filing is published and are weighted by the size of the holding.
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Holding Returns | |||||||
|---|---|---|---|---|---|---|---|
| Stock | Put/Call | Change | Holding Pct | Value | Current Return | 3M Return | 1Y Return |
| SGEN - Seagen Inc. | Reduce 5% $(454.1M) | 49.63% | $8.6B | +9.20% | |||
| INCY - Incyte Corporation | 13.03% | $2.3B | +0.23% | -15.30% | -4.98% | ||
| BGNE - BeiGene, Ltd. | 12.04% | $2.1B | +20.26% | -3.76% | -6.52% | ||
| ACAD - ACADIA Pharmaceuticals Inc. | Add 2% ($22.2M) | 5.94% | $1.0B | -23.16% | -19.59% | -45.14% | |
| MDGL - Madrigal Pharmaceuticals, Inc. | 2.07% | $356.9M | +60.03% | -6.01% | +42.14% | ||
| BMRN - BioMarin Pharmaceutical Inc. | 1.91% | $330.3M | -35.62% | -3.48% | -1.13% | ||
| IMCR - Immunocore Holdings plc | 0.87% | $151.1M | -37.97% | -18.75% | -37.71% | ||
| N/A - Invitae Corporation | New Purchase | 0.78% | $135.0M | ||||
| KOD - Kodiak Sciences Inc. | 0.69% | $119.4M | +19.30% | -29.12% | -9.12% | ||
| AKRO - Akero Therapeutics, Inc. | 0.64% | $110.6M | +4.24% | -69.24% | -48.94% | ||
| ARGX - argenx SE | 0.63% | $109.2M | +13.72% | -3.39% | +4.13% | ||
| RYTM - Rhythm Pharmaceuticals, Inc. | 0.62% | $107.2M | +130.82% | +20.70% | +75.76% | ||
| REPL - Replimune Group, Inc. | 0.62% | $106.3M | -54.39% | -43.32% | -47.69% | ||
| ABCL - AbCellera Biologics Inc. | Add 57% ($38.8M) | 0.62% | $106.3M | -63.93% | -19.11% | -53.21% | |
| KYMR - Kymera Therapeutics, Inc. | Add 52% ($34.4M) | 0.58% | $100.6M | +48.35% | -9.46% | +120.42% | |
| ROIV - Roivant Sciences Ltd. | Add 97% ($46.9M) | 0.55% | $95.0M | -6.23% | -22.61% | -3.50% | |
| BCRX - BioCryst Pharmaceuticals, Inc. | 0.52% | $89.5M | +50.35% | -27.13% | +6.71% | ||
| SWTX - SpringWorks Therapeutics, Inc. | Add 9% ($6.5M) | 0.46% | $78.7M | +59.37% | -24.70% | +23.54% | |
| TRDA - Entrada Therapeutics, Inc. | 0.43% | $73.7M | -50.36% | +6.73% | +6.21% | ||
| RVMD - Revolution Medicines, Inc. | 0.42% | $72.0M | +30.98% | -29.06% | +44.68% | ||
| IMTX - Immatics N.V. | Add 9% ($5.2M) | 0.38% | $65.1M | -55.56% | -26.38% | -5.19% | |
| KDNY - Chinook Therapeutics, Inc. | 0.32% | $55.9M | |||||
| MRTX - Mirati Therapeutics, Inc. | 0.29% | $50.9M | +39.06% | ||||
| DICE - DICE Therapeutics, Inc. | 0.28% | $48.1M | |||||
| BMEA - Biomea Fusion, Inc. | 0.27% | $46.3M | -92.36% | -50.64% | -69.14% | ||
| PRLD - Prelude Therapeutics Inc. | 0.26% | $45.6M | -75.86% | -7.63% | +57.22% | ||
| DNLI - Denali Therapeutics Inc. | Add 34% ($10.8M) | 0.25% | $42.9M | -45.13% | -23.41% | -1.91% | |
| KNSA - Kiniksa Pharmaceuticals, Ltd. | 0.23% | $39.6M | +60.38% | -7.80% | +53.40% | ||
| CERS - Cerus Corporation | 0.23% | $39.5M | -33.51% | -9.42% | +14.66% | ||
| NRIX - Nurix Therapeutics, Inc. | 0.22% | $38.8M | +17.59% | -28.65% | +145.13% | ||
| RARE - Ultragenyx Pharmaceutical Inc. | Add 66% ($14.4M) | 0.21% | $36.1M | -10.31% | +3.00% | +36.35% | |
| AVTE - Aerovate Therapeutics, Inc. | 0.19% | $33.7M | -2.87% | -88.07% | |||
| IGMS - IGM Biosciences, Inc. | 0.17% | $29.1M | -84.61% | -28.48% | +12.36% | ||
| XENE - Xenon Pharmaceuticals Inc. | 0.17% | $28.9M | -22.98% | -22.18% | +2.11% | ||
| IMGN - ImmunoGen, Inc. | New Purchase | 0.17% | $28.7M | +3.44% | |||
| DBVT - DBV Technologies S.A. | 0.16% | $27.8M | -47.32% | -46.37% | -70.19% | ||
| VERV - Verve Therapeutics, Inc. | 0.15% | $26.6M | -73.54% | -31.69% | -73.01% | ||
| TSVT - 2seventy bio, Inc. | 0.15% | $25.3M | -63.88% | -28.84% | |||
| IDYA - IDEAYA Biosciences, Inc. | Add 28% ($5.4M) | 0.14% | $25.0M | -20.47% | +18.59% | +52.38% | |
| STOK - Stoke Therapeutics, Inc. | Add 1% ($157.6K) | 0.13% | $22.6M | +75.05% | -15.41% | +161.47% | |
| BCYC - Bicycle Therapeutics plc | 0.12% | $21.5M | -62.57% | -29.92% | +3.46% | ||
| GLUE - Monte Rosa Therapeutics, Inc. | New Purchase | 0.12% | $20.7M | -36.28% | -43.90% | -25.30% | |
| CABA - Cabaletta Bio, Inc. | Add 19% ($3.2M) | 0.12% | $20.6M | -86.08% | +29.34% | -66.79% | |
| KRYS - Krystal Biotech, Inc. | Reduce 44% $(15.6M) | 0.12% | $20.0M | +5.36% | -16.72% | +62.26% | |
| SMMT - Summit Therapeutics Inc. | New Purchase | 0.09% | $15.8M | +815.33% | -0.50% | +496.48% | |
| ANAB - AnaptysBio, Inc. | 0.09% | $15.8M | +15.30% | -25.36% | +68.31% | ||
| PRME - Prime Medicine, Inc. | 0.09% | $15.1M | -90.29% | -46.34% | -63.87% | ||
| PACB - Pacific Biosciences of California, Inc. | 0.09% | $15.0M | -91.60% | -31.91% | -85.27% | ||
| RLAY - Relay Therapeutics, Inc. | New Purchase | 0.08% | $14.6M | -72.43% | -21.42% | -38.69% | |
| SPRY - ARS Pharmaceuticals, Inc. | 0.08% | $13.4M | +109.13% | -34.35% | +96.23% | ||
| RNA - Avidity Biosciences, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| BPMC - Blueprint Medicines Corporation | Reduce 100% | 0.00% | $0.00 | ||||
| FGEN - FibroGen, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| HRTX - Heron Therapeutics, Inc. | Reduce 100% | 0.00% | $0.00 | ||||
| NVTA - Invitae Corporation | Reduce 100% | 0.00% | $0.00 | ||||